PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (NDC: 64679-953-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.

Reported: July 29, 2015 Initiated: April 22, 2015 #D-1260-2015

Product Description

Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (NDC: 64679-953-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.

Reason for Recall

CGMP Deviations: Firm did not adequately investigate customer complaints.

Details

Recalling Firm
Wockhardt Usa Inc.
Units Affected
A) 63,203 Bottles and B) 6,094 Bottles.
Distribution
U.S. Nationwide including Puerto Rico.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets USP, 30 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-953-01) and B) 500 Count Bottles (NDC: 64679-953-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.. Recalled by Wockhardt Usa Inc.. Units affected: A) 63,203 Bottles and B) 6,094 Bottles..
Why was this product recalled?
CGMP Deviations: Firm did not adequately investigate customer complaints.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 29, 2015. Severity: Moderate. Recall number: D-1260-2015.